Literature DB >> 20464493

Influence of MDR1 polymorphism on H. pylori-related chronic gastritis.

Tomomitsu Tahara1, Tomoyuki Shibata, Hiromi Yamashita, Ichiro Hirata, Tomiyasu Arisawa.   

Abstract

BACKGROUND: There is evidence that changes in MDR1 function and/or expression contribute to the pathogenesis of inflammatory disorders of the gastrointestinal tract. AIMS: We aimed to investigate the effect of C3435T polymorphism of the MDR1 gene on histological chronic gastritis, and on the risk of peptic ulcer diseases.
METHODS: Restriction fragment length polymorphism analysis was performed for polymorphisms at C3435T in the MDR1 gene in 556 cancer-free subjects including 116 gastric and 60 duodenal ulcers, and 380 non-ulcer subjects. Gastritis scores in the antrum were assessed according to the updated Sydney system in 384 subjects.
RESULTS: We did not find a significant association between MDR1 genotype and gastritis scores in any of the 384 subjects. However, the 3435T carrier was significantly associated with a higher degree of neutrophil infiltration in H. pylori-positive subjects (CC vs. T carrier: p=0.0495). When the H. pylori positive subjects were divided according to generation, the 3435T carrier was significantly associated with a higher degree of neutrophil infiltration in subjects more than 65 years of age (CC vs. T carrier: p=0.03). Also, the MDR1 3435 TT genotype was significantly associated with a higher degree of atrophy and intestinal metaplasia in the same generation (atrophy, TT vs. C carrier: p=0.038, intestinal metaplasia, TT vs. C carrier: p=0.016). No association was found between MDR1 genotypes and risk of peptic ulcer diseases.
CONCLUSIONS: It appears that the C3435T polymorphism of MDR1 influences H. pylori-related inflammatory conditions in the stomach, especially in older subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464493     DOI: 10.1007/s10620-010-1251-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; A Rzhetsky; R Allikmets
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 2.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

3.  Risk of gastric cancer in patients with non-surgically treated peptic ulcer.

Authors:  S Lee; M Iida; T Yao; S Shindo; Y Nose; K Akazawa; H Okabe; M Fujishima
Journal:  Scand J Gastroenterol       Date:  1990-12       Impact factor: 2.423

Review 4.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

5.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

Authors:  Marek Droździk; Monika Białecka; Katarzyna Myśliwiec; Krystyna Honczarenko; Jan Stankiewicz; Zbigniew Sych
Journal:  Pharmacogenetics       Date:  2003-05

Review 6.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

7.  Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis.

Authors:  Gerardo Nardone; Alba Rocco; Dino Vaira; Stefania Staibano; Alfredo Budillon; Fabiana Tatangelo; Maria G Sciulli; Federico Perna; Gaetano Salvatore; Maria Di Benedetto; Gaetano De Rosa; Paola Patrignani
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

8.  Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats.

Authors:  J Kalitsky-Szirtes; A Shayeganpour; D R Brocks; M Piquette-Miller
Journal:  Drug Metab Dispos       Date:  2004-01       Impact factor: 3.922

9.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Naohito Shirai; Chise Kodaira; Masafumi Nishino; Mihoko Yamade; Mutsuhiro Ikuma; Haruhiko Sugimura; Takashi Ishizaki; Akira Hishida
Journal:  Life Sci       Date:  2008-07-03       Impact factor: 5.037

View more
  3 in total

1.  The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis.

Authors:  Meng Li; Taijie Li; Shihui Guo; Hongjie Liang; Dunke Jiang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

2.  Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation.

Authors:  Kalluri Thishya; Kiran Kumar Vattam; Shaik Mohammad Naushad; Shree Bhushan Raju; Vijay Kumar Kutala
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

3.  Association between single genetic polymorphisms of MDR1 gene and gastric cancer susceptibility in Chinese.

Authors:  Wen Qiao; Tao Wang; Li Zhang; Qing Tang; Dan Wang; Hongkun Sun
Journal:  Med Oncol       Date:  2013-06-26       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.